CSL was a long time in the making and unbeknown to many it had one of the longest serving CEO's in corporate Australia. In my view this is one that every SMSF should have. To see CYP even achieve a quarter of what they have in a lesser time-frame would be awesome. CYP would not to upshift its business model in the future though if it wanted to be in the comparative game for cell technology as CSL is in blood technologies.
CSL was a long time in the making and unbeknown to many it had...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.0¢ |
Change
-0.010(4.17%) |
Mkt cap ! $41.55M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 25.0¢ | 23.0¢ | $8.016K | 33.31K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 21232 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 16645 | 2 |
View Market Depth
| Last trade - 15.46pm 21/10/2024 (20 minute delay) ? |
| CYP (ASX) Chart |